Phase I/II clinical trial of enzyme replacement therapy with idursulfase beta in patients with mucopolysaccharidosis II (Hunter Syndrome)

Overview of attention for article published in Orphanet Journal of Rare Diseases, March 2013

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (70th percentile)
Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

twitter: 4 X users
facebook: 1 Facebook page

googleplus: 1 Google+ user

Citations

dimensions_citation: 66 Dimensions

Readers on

mendeley: 117 Mendeley
citeulike: 2 CiteULike

Summary X Facebook Google+ Dimensions citations

So far, Altmetric has seen 1 Google+ post.

Mitul Sarkar, 29 Sep 2013

Rare diseases, drug companies and drug affordability Many years ago, as the doctor on the night-shift... Rare diseases, drug…

This page shows the most recent Google+ posts that mention this research output.

Click here to find out how to access more activity.